Literature DB >> 17447954

Semiparametric bayesian inference for multilevel repeated measurement data.

Peter Müller1, Fernando A Quintana, Gary L Rosner.   

Abstract

We discuss inference for data with repeated measurements at multiple levels. The motivating example is data with blood counts from cancer patients undergoing multiple cycles of chemotherapy, with days nested within cycles. Some inference questions relate to repeated measurements over days within cycle, while other questions are concerned with the dependence across cycles. When the desired inference relates to both levels of repetition, it becomes important to reflect the data structure in the model. We develop a semiparametric Bayesian modeling approach, restricting attention to two levels of repeated measurements. For the top-level longitudinal sampling model we use random effects to introduce the desired dependence across repeated measurements. We use a nonparametric prior for the random effects distribution. Inference about dependence across second-level repetition is implemented by the clustering implied in the nonparametric random effects model. Practical use of the model requires that the posterior distribution on the latent random effects be reasonably precise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447954      PMCID: PMC3074472          DOI: 10.1111/j.1541-0420.2006.00668.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

Review 1.  Multilevel modelling of medical data.

Authors:  Harvey Goldstein; William Browne; Jon Rasbash
Journal:  Stat Med       Date:  2002-11-15       Impact factor: 2.373

2.  A semiparametric Bayesian approach to the random effects model.

Authors:  K P Kleinman; J G Ibrahim
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

3.  A semi-parametric Bayesian approach to generalized linear mixed models.

Authors:  K P Kleinman; J G Ibrahim
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

4.  Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.

Authors:  S M Lichtman; M J Ratain; D A Van Echo; G Rosner; M J Egorin; D R Budman; N J Vogelzang; L Norton; R L Schilsky
Journal:  J Natl Cancer Inst       Date:  1993-08-18       Impact factor: 13.506

  4 in total
  5 in total

1.  Bayesian Hierarchical Semiparametric Modelling of Longitudinal Post-treatment Outcomes from Open Enrolment Therapy Groups.

Authors:  Susan M Paddock; Terrance D Savitsky
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2013-06-01       Impact factor: 2.483

2.  Bayesian Semi- and Non-parametric Models for Longitudinal Data with Multiple Membership Effects in R.

Authors:  Terrance D Savitsky; Susan M Paddock
Journal:  J Stat Softw       Date:  2014-03       Impact factor: 6.440

3.  A BAYESIAN TIME-VARYING EFFECT MODEL FOR BEHAVIORAL MHEALTH DATA.

Authors:  Matthew D Koslovsky; Emily T Hébert; Michael S Businelle; Marina Vannucci
Journal:  Ann Appl Stat       Date:  2020-12-19       Impact factor: 2.083

4.  A Bayesian semiparametric model for bivariate sparse longitudinal data.

Authors:  Kiranmoy Das; Runze Li; Subhajit Sengupta; Rongling Wu
Journal:  Stat Med       Date:  2013-04-04       Impact factor: 2.373

5.  A Semiparametric Bayesian Model for Repeatedly Repeated Binary Outcomes.

Authors:  Fernando A Quintana; Peter Müller; Gary L Rosner; Mary V Relling
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2008-05-28       Impact factor: 1.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.